When injectable diabetes therapy becomes necessary. Insulin or GLP-1 analogs?
Stiefelhagen, P.
MMW Fortschritte der Medizin 153(1-2): 14
2011
ISSN/ISBN: 1438-3276 PMID: 24761480 Document Number: 651037
Document emailed within 1 workday
Related Documents
Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452Matthaei, S.; Hamann, A. 1997: Current insulin therapy. Treatment with new short-acting and retard insulin analogs Fortschritte der Medizin 115(12): 35-6 39
Lundershausen, R.; Potthoff, F.; Häuser, C.; Kaiser, M.; Münscher, C. 2006: Human insulin vs. analogs. What is the cost of supplementary insulin therapy? MMW Fortschritte der Medizin 148(45): 42
Bringer, J.; Galtier-Dereure, F.; Augustin-Pascalis, I.; Richard, J.L.; Parer-Richard, C.; Mirouze, J.; Jaffiol, C. 1993: Provisional intensive insulin therapy in non-insulin-dependent diabetes resistant to usual treatment Journees Annuelles de Diabetologie de l'Hotel-Dieu 1993: 115-122
Afanas'eva, S.N. 1982: Insulin therapy and the nature of immunologic reactions to insulin and pancreatic tissue in diabetes mellitus Terapevticheskii Arkhiv 54(10): 30-32
Mozdzan, M.ł; Mozdzan, M.; Loba, J.; Markuszewski, L.; Ruxer, J. 2006: Effect of short-term intensive insulin therapy on daily insulin requirement in poorly controlled type 2 diabetes patients Wiadomosci Lekarskie 59(3-4): 203-207
Ametov, A.S.; Kochergina, I.I.; Ulanova, K.A. 2010: Effect of insulin therapy on insulin resistance and risk for ischemic heart disease and death from cardiovascular pathology in patients with diabetes mellitus, type 2 Terapevticheskii Arkhiv 82(3): 42-46
Jungmann, E.; Helling, T.; Jungmann, G.; Mertens, C.; Snelting, U. 2001: Intensified conventional insulin therapy in patients with type 2 diabetes mellitus. Positive long-term effects of insulin lispro on metabolic control and microalbuminuria Fortschritte der Medizin. Originalien 118(4): 141-146
Jungmann, E. 1997: From human insulin to designer insulin. Why insulin analogs? Fortschritte der Medizin 115(12): 40-41
Krawczuk-Rybak, M.; Wójtowicz, J.; Urban, M. 1992: Lipid metabolism in patients with insulin dependent diabetes. IV. Effect of sex, age, excess body weight, duration of diabetes, insulin dosage and family history on lipid metabolism in patients with insulin dependent diabetes Endokrynologia Polska 43(2): 125-135
Muñoz, S.; Durruty, P.; García de los Ríos, M. 1987: Phenotypic characteristics and insulin secretion in 25 cases of non-insulin-dependent diabetes mellitus, subtype MODY (maturity onset diabetes in the young people) Revista Medica de Chile 115(5): 397-403
Sánchez Sánchez, O.; Sabán Ruiz, Jé. 2008: Lights and shades in the application of new guidelines for the management of type 2 diabetes mellitus. Practical advice about combined therapy and insulin therapy Medicina Clinica 130(5): 188-196
Miller, E.M. 2017: Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Role of Injectable Medications in Type 2 Diabetes Treatment Journal of Family Practice 66(10 Suppl): S4-S6
Martin, S. 1998: Intensified insulin therapy in type i diabetes: when and how? Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 92(7): 475-480
Keller, U.; Straumann, E.; Berger, W. 1988: Intensified insulin therapy in Type-i diabetes Schweizerische Rundschau für Medizin Praxis 77(9): 213-217
Heile, M.; Schneider, D. 2012: The evolution of insulin therapy in diabetes mellitus Journal of Family Practice 61(5 Suppl): S6-12
Kränzlin, H.; Zilker, T.; Ermler, R.; Bottermann, P. 1975: Diabetes therapy in relation to insulin secretion Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 1478-1481
Fernández Landó, L.; Massari, F.; Oviedo, A.; Jiang, H. 2012: Starting an insulin regimen with insulin lispro mix 25 versus glargine insulin for type 2 diabetes Medicina 72(3): 235-242
Beck-Nielsen, H.; Henriksen, J.E.; Alford, F.; Hother-Nielson, O. 1996: In vivo glucose metabolism, insulin secretion and, insulin action in Europids with non-insulin-dependent diabetes mellitus (NIDDM) and their first-degree relatives Diabetic Medicine: a Journal of the British Diabetic Association 13(9 Suppl 6: S78-S84
Siddiqui, N.I. 2007: Evaluation of inhaled insulin therapy for diabetes mellitus Mymensingh Medical Journal: Mmj 16(2): 237-245